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Faheem G Sheriff*, William P Howlett and Kajiru G KilonzoAbstract
Background: Pituitary disorders following pregnancy are an important yet under reported clinical entity in the
developing world. Conversely, post partum panhypopituitarism has a more devastating impact on women in such
settings due to high fertility rates, poor obstetric care and scarcity of diagnostic and therapeutic resources available.
Case presentation: A 37 year old African female presented ten years post partum with features of multiple
endocrine deficiencies including hypothyroidism, hypoadrenalism, lactation failure and secondary amenorrhea. In
addition she had clinical features of an underlying autoimmune condition. These included a history of post-partum
thyroiditis, alopecia areata, livedo reticularis and deranged coagulation indices. A remarkable clinical response
followed appropriate hormone replacement therapy including steroids. This constellation has never been reported
before; we therefore present an interesting clinical discussion including a brief review of existing literature.
Conclusion: Post partum pituitary insufficiency is an under-reported condition of immense clinical importance
especially in the developing world. A high clinical index of suspicion is vital to ensure an early and correct
diagnosis which will have a direct bearing on management and patient outcome.
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The pituitary gland undergoes major anatomic, physio-
logic and immunologic changes during pregnancy. Its
enlargement is chiefly attributed to lactotroph hyperplasia
[1]. These changes then predispose the pregnant woman
to a spectrum of pituitary disorders in the intra-partum
and post-partum periods. These include Sheehan’s syn-
drome which is by far the commonest, lymphocytic hypo-
physitis and rarely, apoplexy of pituitary adenomas [1,2].
Sheehan’s syndrome (SS) is becoming increasingly rare
in the developed world due to improved standards of
obstetric care; the same is not yet true for the developing
world. The prevalence of women of reproductive age with* Correspondence: fsheriff.md@gmail.com
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reproduction in any medium, provided the orsuspected SS in the Kashmir valley (Indian subcontinent)
was estimated at 3.2% [3]. Similar cross-sectional studies
are virtually non-existent for Africa but a couple of case
series have appeared in the literature. Cénac et al reported
40 cases of SS within a 5-year period at a hospital in Niger.
All their patients were black African women living in rural
areas and had no medical assistance during the last deliv-
ery [4]. Another group of researchers from Senegal noted
that the main risk factors were traditions of home delivery
and lack of obstetric care [5]. In addition, they observed
a long latency period before the disease manifestations
became overt [5]. Not surprisingly, lymphocytic adenohy-
pophysitis with an estimated annual incidence in the UK of
one case per 9 million [6], is even less commonly reported
in sub-Saharan Africa with only a couple of isolated case
reports till date from South Africa [7,8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Relevant laboratory results
CBC/ESR Hb= 96.6 g/L (121–153), MCV= 83.3 fL (82–103),
ESR = 60 mm/hr (0–10)
Coagulation panel International Normalized Ratio (INR): 2.06 (1.0-1.5).
The patient was not on any oral anti-coagulants;
this had normalized on a follow-up exam.
Activated Partial Thromboplastin Time(APTT):
31.15 sec (20–35)
Chemistry panel Fasting blood glucose: 3.2 mmol/L (3.6 -6.3),
Na+: 113.9 mmol/L (137–147), K+: 3.4 mmol/L
(3.4-5.3), aspartate aminotransferase (AST):
83.6 IU/L (11–47); creatinine: 67 mcmol/L
(44–150)
Dipstick urinalysis proteinuria 2+, specific gravity: 1.030 (1.010-1.025)
Endocrine panel T4: 38 ng/mL (60–160), T3: 0.8 ng/mL (1.0-3.1),
TSH: 0.0 uIU/ml (0.4-6.2); LH, FSH, ACTH, GH,
prolactin and cortisol could not be tested due
to lack of reagents
Autoimmune panel ANA (anti-nuclear antibody) titres less than 1:40;
Anti-cardiolipin and anti-B2-glycoprotein IgM /
IgG were all within normal limits. Thyroid auto-
antibodies and angiotensin converting enzyme
(ACE) levels could not be tested.
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History
ZM, a 37 year old multiparous woman from Northern
Tanzania, presented with complaints of generalized body
swelling associated with progressive weight gain for ten
years. The onset coincided with her last child birth which
was complicated by mild post-partum haemorrhage fol-
lowing which she failed to lactate. She also experienced
cold intolerance, loss of libido and a complete cessation
of her menses. Four years prior admission she had had a
serious febrile illness following which she experienced a
brief period of altered level of consciousness and transient
aphasia; since then she noted slowing of speech. As part
of her systems review, she reported an anterior neck
swelling which increased during her last pregnancy then
gradually subsided a few months later. She also reported
headaches of moderate intensity but no gross visual
changes; she suffered from occasional rashes in sunlight
exposed areas but no mucosal ulceration. Her past med-
ical history revealed no previously diagnosed chronic ill-
nesses; she was sero-negative for HIV and syphilis. Her
obstetric history revealed she had a parity of five with four
living children (one still birth at term with no obvious
congenital malformations noted). Since she had received
no formal antenatal care, there were no records of blood
pressure measurements during pregnancy. All were home
deliveries in the absence of a qualified birth attendant.
Physical examination
Vitals: Pulse: 70/min; BP: 102/68 mm Hg; Temp: 36.2
degrees C; Respiratory rate 14/min. Orthostatics: Supine
BP 110/80 mm Hg, standing BP 95/60 mm Hg. General/
endocrine: overweight woman (BMI 29. 1 kg/m2), look-
ing younger than her stated age. She was pale with gener-
alized, non-pitting edema involving face and extremities.
Of note she had no oral ulcers and her thyroid gland was
not palpable. She had “alabaster” skin with patchy hair
loss over scalp; sparse axillary and pubic hair. Cardio-
vascular: Regular rate and rhythm with distant heart
sounds. Respiratory/Abdominal exams were unremark-
able. Neurologic Exam: Higher centres: Fully oriented to
time, place and person but with marked slowing of speech
and mentation. Cranial nerves: Optic nerve- Visual acuity
20/30 both eyes; gross visual fields normal at bedside.
Fundoscopy: no papilledema noted. Extra-ocular move-
ments were intact. Motor: Limbs hypotonic; power
reduced to grade 4/5 MRC (Medical Research Council
grade) with proximal weaker than distal muscle groups.
Reflexes: Ankle jerks were delayed and plantar responses
flexor. Sensation was normal for all modalities tested.
Investigations
Labs
Please see Table 1.Computerized visual perimetry
Minor field defects were noted in both temporal fields.
Radiology
Chest X-ray: cardiomegaly, small left sided pleural effu-
sion; Echo: 15 mm pericardial effusion, normal left ven-
tricular function; X-ray of Sella: no evidence of mass
lesion, symmetric floor (Figure 1); Non-contrast axial
head CT scan: possible asymmetric density within the
sella turcica (but no ‘empty sella’ sign); dorsum sellae
poorly visualized (Figure 2).
Management and progress in wards
The patient was started on hormone replacement ther-
apy including thyroxine 50 mcg daily, prednisone
5 mg AM and 2.5 mg PM and a combined oral contra-
ceptive. During her stay in the wards the patient’s condi-
tion deteriorated abruptly due to an adrenal crisis
probably precipitated by the vigorous thyroid hormone
replacement. The dose of thyroxine was lowered to 25
mcg daily and the patient kept on normal saline and IV
hydrocortisone 100 mg 6hourly. In addition, severe
hyponatremia should be managed with water restriction
and hypertonic saline infusion; the latter was avoided
because of the difficulty monitoring Na+ levels and the
associated risk of osmotic demyelination syndrome.
Upon discharge three weeks later her rate of speech,
mentation and exercise tolerance was significantly better
compared to admission. On a two-month follow-up visit,
there was a marked reduction in the generalised edema.
The thyroxine dosage was subsequently increased grad-
ually to 100 mcg daily. Her hair pattern had normalized
in three months. At her five-month follow up visit, it
Floor of Sella turcica
Figure 1 Sella turcica X-ray (lateral view). Legend: No evidence of mass lesion seen, symmetric floor with no erosion or `double floor` sign.
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her lower extremities bilaterally. (Figure 3) She was sub-
sequently started on anti platelet therapy (junior aspirin
75 mg daily) and the oral contraceptive stopped. The
livedo reticularis had disappeared on a subsequent visit.
At 16 months, the patient was in good general health
except for a headache and occasional palpitations. At this
juncture, the thyroxine dose was lowered to 75 mcg daily.
Differential diagnosis
This patient has anterior pituitary insufficiency begin-
ning in the post partum period. NeurohypophysealFigure 2 Non-contrast axial head CT scan (at the level of sella). Legend
(but no ‘empty sella’ sign); dorsum sellae poorly visualized.involvement is unlikely given the persistently elevated
urine specific gravity even post steroid therapy which
essentially rules out diabetes insipidus. The most likely
differentials are lymphocytic hypophysitis (LyHy) and
Sheehan’s syndrome. An underlying co-morbid auto-
immune condition such as systemic lupus erythema-
tosus (SLE) or anti-phospholipid syndrome is a relevant
clinical consideration but is made less likely given
her negative antibody screens. Neoplasms and other
granulomatous disorders of the hypophysis (tuber-
culosis, syphilis, sarcoidosis and histiocytosis X) are
also possibilities but would be lower on the list ofdorsum sellae
possible asymmetric
density
: Possible asymmetric density within the pituitary gland on the left
Figure 3 Photograph of proximal left lower extremity at five-month follow up visit. Legend: appearance of diffuse reticular rash consistent
with livedo reticularis.
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laboratory evidence.
Discussion
In this patient, the diagnosis of anterior pituitary insuffi-
ciency is evident from the constellation of secondary
hypothyroidism, secondary amenorrhoea and the clinicalmanifestations of secondary adrenocortical insufficiency
(hypoglycaemia, orthostatic hypotension and marked
hyponatremia with low normal K+ levels). Interestingly,
her TSH levels were undetectable which is quite rare in
panhypopituitarism but has been previously reported [9].
Also noteworthy in this case is the severe hyponatremia
which is likely multifactorial. In secondary adrenal
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cortisolism leads to failure of inhibition of vasopressin
secretion. In addition severe secondary hypothyroidism,
which this patient also had, leads to a syndrome of
inappropriate secretion of ADH (SIADH)-like picture
[10-12].
Arriving at an etiologic diagnosis is more challenging.
The history of post-partum hemorrhage albeit mild, and
lactation failure may favor Sheehan’s syndrome (SS)
over lymphocytic hypophysitis (LyHy) which is another
recognized, but less common cause of post-partum pitu-
itary insufficiency [1,2]. However in light of a history
suggestive of painless post-partum thyroiditis, a physical
exam which revealed signs of co-existing autoimmune
conditions such as alopecia areata and the elevated ESR,
the latter provides a better diagnostic fit [2,9,13,14].
While LyHy often presents with hyperprolactinemia
from stalk dysfunction leading to galactorrhoea in a
quarter to one-third of cases [1,6], agalactia has been
reported in 11% of patients [6].
Although, thyroid auto-antibodies could not be tested
and her antinuclear antibody and antiphospholipid anti-
bodies were negative, a comprehensive retrospective
analysis of 379 patients with lymphocytic hypophysitis
(LyHy) by Caturgeli et al found that the prevalence of
auto-antibodies for Hashimoto’s and SLE was only 7.4%
and 1.3% respectively [6]. Similarly; anti-pituitary anti-
bodies could not be assayed however these are consid-
ered of limited sensitivity and specificity in the diagnosis
of lymphocytic hypophysitis since they are present in
other autoimmune conditions and several non-immune
pituitary disorders (including Sheehan’s syndrome) [6].
In the latter, post partum hemorrhage may trigger pituit-
ary autoimmunity by the release of sequestered antigens
following necrosis of the gland [15].
Assessment of visual fields is a simple but very useful
diagnostic test. The minor defect in the patient’s tem-
poral visual fields detected bilaterally upon visual perim-
etry may signify an ischemic process secondary to a
mass effect at the optic chiasm – this could indicate a
pituitary macroadenoma or an infiltrative process such
as LyHy. The normal size sella on skull X-ray and CT
scan might argue against a large tumor.
MRI is the imaging study of choice for the pituitary
[16], the lack of which makes it difficult to accurately
diagnose pituitary disease in most hospitals in the devel-
oping world. In any case, up to 9% of patients suffering
from LyHy have normal imaging findings on CT/MRI.
More common presentations include symmetric enlarge-
ment of sellar content (66%), thickening of the pituitary
stalk (56%), homogenous enhancement (51%) and occa-
sionally asymmetry of the enlarged sellar content (18%)
[17]. This differs from the imaging findings in Sheehan’s
syndrome which almost always results in a partially orcompletely empty sella that may be normal or reduced
in size [18,19].
A definitive diagnosis usually requires a tissue biopsy
often obtained via the endonasal transsphenoidal approach
which was not possible in this case. Molitch et al have
suggested criteria for making a strong presumptive clinical
diagnosis non-invasively. These are as follows: a history
of gestational / postpartum hypopituitarism, a contrast-
enhancing sellar mass with MRI features characteristic of
LyHy, a pattern of endocrine deficiency with early loss of
adrenocorticotrophic hormone and thyroid-stimulating
hormone unlike that found with macroadenomas and
pituitary failure disproportionate to size of the mass [20].
Of note, livedo reticularis has never been reported
before in patients with a clinical or histopathologic diag-
nosis of lymphocytic hypophysitis and may be unrelated.
However, an association is not inconceivable particularly
if the patient were to have an underlying co-morbidity
such as SLE, since both LyHy and livedo reticularis have
independently been documented in lupus [21,22]. This
patient likely meets four (4) of the eleven (11) criteria
required for a diagnosis of lupus namely photosensitivity,
proteinuria, serositis (pleural and pericardial effusions)
and hematologic abnormalities (normocytic anemia) [23].
However her ANA was negative and more specific tests
such as anti-ds DNA or anti-Sm antibodies to rule out
antinuclear-antibody negative disease were not available.
Finally, does a definitive diagnosis necessarily influence
management in post-partum panhypopituitarism? The
simple answer is yes - while hormone replacement is
often all that is necessary for Sheehan’s syndrome, add-
itional measures may be required for patients with LyHy
presenting with symptoms of sellar compression. While
surgery or pituitary radiotherapy may eventually be
needed, in the absence of urgent visual symptoms it is
reasonable to advocate using high dose glucocorticoids
as first line therapy for LyHy under imaging surveillance
if possible; decrease in volume of the pituitary mass and
improving hormone status helps to confirm the diagno-
sis retrospectively [6,17]. Methotrexate and azathioprine
can be used for poor responders [24-26]. Among the
320 patients with LyHy followed by Caturgeli, 73%
required long term hormone replacement therapy, 16%
recovered following mass-reduction without need for
hormone-replacement, 8% died probably from irrevers-
ible adrenal insufficiency and 3% experienced spontan-
eous resolution without treatment [6].
Conclusion
In the developing world, post-partum pituitary insuffi-
ciency is not altogether a rare clinical entity. The differ-
ential diagnosis becomes more challenging if clinical
features suggestive of an auto-immune condition are
also present. An accurate history and a keen physical
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and appropriately managing such patients especially in
resource limited settings. A specific diagnosis may allow
effective use of pharmacologic therapy before resorting
to more invasive measures. There is a dire need for edu-
cating health care professionals and the general public
since the disorder left undiagnosed has a devastating
impact on maternal morbidity and mortality; properly
designed epidemiologic studies to quantify the exact
magnitude of the problem will be a necessary step
towards the solution.
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